Enovix Corp Files 8-K with Corporate Updates

Ticker: ENVX · Form: 8-K · Filed: 2025-07-02T00:00:00.000Z

Sentiment: neutral

Topics: corporate-filing, 8-K, company-information

Related Tickers: ENVX

TL;DR

Enovix filed an 8-K on July 2nd, updating corporate info. Check their Fremont HQ address and contact details.

AI Summary

Enovix Corporation filed an 8-K on July 2, 2025, reporting other events and financial statements. The filing details the company's principal executive offices located at 3501 W. Warren Avenue, Fremont, California, 94538, and its phone number (510) 695-2350. The report also notes Enovix Corporation's incorporation in Delaware and its IRS Employer Identification Number.

Why It Matters

This 8-K filing provides essential corporate information and updates for Enovix Corporation, which is relevant for investors and stakeholders tracking the company's official disclosures.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases or decreases risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Enovix Corporation?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of July 2, 2025.

Where are Enovix Corporation's principal executive offices located?

Enovix Corporation's principal executive offices are located at 3501 W. Warren Avenue, Fremont, California, 94538.

What is the telephone number for Enovix Corporation?

The telephone number for Enovix Corporation, including area code, is (510) 695-2350.

In which U.S. state is Enovix Corporation incorporated?

Enovix Corporation is incorporated in Delaware.

What is Enovix Corporation's IRS Employer Identification Number?

Enovix Corporation's IRS Employer Identification Number is 85-3174357.

From the Filing

0001828318-25-000220.txt : 20250702 0001828318-25-000220.hdr.sgml : 20250702 20250702083151 ACCESSION NUMBER: 0001828318-25-000220 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250702 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250702 DATE AS OF CHANGE: 20250702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enovix Corp CENTRAL INDEX KEY: 0001828318 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] ORGANIZATION NAME: 04 Manufacturing EIN: 853174357 FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39753 FILM NUMBER: 251098409 BUSINESS ADDRESS: STREET 1: 3501 W. WARREN AVENUE CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 510 695-2350 MAIL ADDRESS: STREET 1: 3501 W. WARREN AVENUE CITY: FREMONT STATE: CA ZIP: 94538 FORMER COMPANY: FORMER CONFORMED NAME: Rodgers Silicon Valley Acquisition Corp DATE OF NAME CHANGE: 20201014 8-K 1 envx-20250702.htm 8-K envx-20250702 0001828318 False 0001828318 2025-06-30 2025-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter)   Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 3501 W Warren Avenue Fremont , California   94538 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: ( 510 ) 695-2350 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share ENVX The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01 Other Events. On July 2, 2025, Enovix Corporation (the “Company”) announced that the Company’s board of directors had authorized the repurchase of up to $60 million worth of shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), effective immediately (the “Repurchase Plan”). Repurchases may be made from time to time through open market purchases or through privately negotiated transactions subject to market conditions, applicable legal requirements and other relevant factors. Open market repurchases may be structured to occur in accordance with the requirements of Rule 10b-18. The timing and number of shares of Common Stock repurchased will depend on a variety of factors, including price, general business and market con

View on Read The Filing